The Borrelial Fibronectin-Binding Protein RevA Is an Early Antigen of Human Lyme Disease
- 1 February 2010
- journal article
- Published by American Society for Microbiology in Clinical and Vaccine Immunology
- Vol. 17 (2) , 274-280
Abstract
Previous studies using small numbers of serum samples from human patients and experimentally infected animals identified the frequent presence of antibodies recognizing RevA, a borrelial fibronectin-binding outer surface protein. We now demonstrate that most examined Lyme disease spirochetes from North America and Europe contain genes encoding RevA proteins, some with extensive regions of conservation and others with moderate diversity. Line blot analyses using recombinant RevA from two diverse Lyme disease spirochetes of RevA and serum samples from culture-confirmed human Lyme disease patients from the United States ( n = 46, mainly with early Lyme disease) and Germany (>500, with early and late manifestations of Lyme disease) were performed. The results indicated that a sizable proportion of patients produced antibodies that recognized recombinant RevA. Overall, RevA-based serological studies were less sensitive and less specific than other assay types, such as the VlsE-based C6 peptide assay. However, sera from patients in the initial stages of Lyme disease contained antibodies against RevA, demonstrating that this protein is expressed early in human infection. Thus, RevA may be a useful target for preventative or curative therapies.Keywords
This publication has 50 references indexed in Scilit:
- Borrelia burgdorferi Sensu Lato Species in Europe Induce Diverse Immune Responses against C 6 Peptides in Infected MiceClinical and Vaccine Immunology, 2009
- Comprehensive seroprofiling of sixteen B. burgdorferi OspC: Implications for Lyme disease diagnostics designClinical Immunology, 2009
- Borrelia burgdorferi RevA Antigen Binds Host FibronectinInfection and Immunity, 2009
- A Genome-Wide Proteome Array Reveals a Limited Set of Immunogens in Natural Infections of Humans and White-Footed Mice withBorrelia burgdorferiInfection and Immunity, 2008
- Borrelia burgdorferiComplement Regulator-Acquiring Surface Protein 2 (CspZ) as a Serological Marker of Human Lyme DiseaseClinical and Vaccine Immunology, 2008
- Antigenicity of borrelial protein BBK32 fragments in early Lyme borreliosisJournal of Medical Microbiology, 2006
- Comparative Genome Hybridization Reveals Substantial Variation among Clinical Isolates ofBorrelia burgdorferiSensu Stricto with Different Pathogenic PropertiesJournal of Bacteriology, 2006
- Serologic Proteome Analysis ofBorrelia burgdorferiMembrane-Associated ProteinsInfection and Immunity, 2006
- Recombinant BBK32 Protein in Serodiagnosis of Early and Late Lyme BorreliosisJournal of Clinical Microbiology, 2002
- European Borrelia burgdorferi isolated from humans and ticks culture conditions and antibiotic susceptibilityZentralblatt für Bakteriologie, Mikrobiologie und Hygiene. Series A: Medical Microbiology, Infectious Diseases, Virology, Parasitology, 1986